Oncotarget, 2017 · DOI: · Published: November 25, 2016
Neuropathic pain is a chronic condition resulting from nerve damage, often resistant to conventional treatments. This study explores the potential of pulsed electromagnetic field (PEMF) therapy to alleviate neuropathic pain induced by chronic constriction injury (CCI) in rats. The researchers investigated the expression of HCN1 and HCN2 mRNA, which are related to nerve function, in rats with CCI-induced neuropathy. They also examined whether PEMF therapy could affect the expression of these mRNA. The study found that CCI led to nerve cell degeneration and reduced expression of HCN1/HCN2 mRNA. While PEMF therapy promoted nerve regeneration and improved pain-related behaviors, it did not restore the expression of HCN1/HCN2 mRNA.
PEMF therapy can promote nerve regeneration and relieve neuropathic pain.
Further investigation is needed to understand the exact mechanisms by which PEMF alleviates neuropathic pain, especially regarding HCN1/2 protein expression.
PEMF could be a valuable treatment option for neuropathic pain, particularly when conventional analgesics are ineffective.